Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Quiet Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: 613 who wrote (147)	2/10/2000 6:15:00 PM
From: QuietWon	Read Replies (1) \| Respond to of 186

IMCL still better - look at the relationships they've been forming - some ppl said this was a one drug co - they're wrong. The past 1-2 months have been great for all biotechs. ONXX has been picking up, too. In Jan/99 when I made those initial comparison posts, ONXX just was not as far along - ONXX needed more time. Now, a year later, ONXX has had the time and doing well. I also like ALLP, CVM, CTII, the gene co's. I think the next direction, as mentioned in a post w/in the past 24 hrs that the biotech wave will probably broaden beyond gene, & cancer to viral co's CVM is an example of that type of co. CTII has GERN-like potential